Christopher T. Middendorf
FDA investigator
Appears on 8 documents from 2011 to 2020, mostly at sites in China. Most often cites general requirements (21 CFR 211.160).
- 8
- Documents on file
- 5.5
- Observations per 483
- 2011
- First seen
- 2020
- Most recent
What they cite most
From 36 observations- 21 CFR 211.160General requirements4
- 21 CFR 211.180General requirements3
- 21 CFR 211.192Production record review3
- 21 CFR 211.22Responsibilities of quality control unit3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.167(a)Special testing requirements2
Activity by year
2011: 1, 2015: 1, 2016: 1, 2018: 2, 2019: 2, 2020: 1
Where
China 5 · Ohio 3
Often inspects with
Is Christopher T. Middendorf coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
8 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2020-04-16 | 483 Wuxi Biologics Co LtdApr 16, 2020 · Wuxi, China | Wuxi, China | 4 | |
| 2019-04-16 | 483 WuXi Biologics Co., Ltd.Apr 16, 2019 · Wuxi, China | Wuxi, China | 4 | |
| 2019-03-22 | 483 Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)Mar 22, 2019 · Wenzhou, China | Wenzhou, China | 3 | |
| 2018-09-13 | 483 CHANGZHOU RUIMING PHARMACEUTICAL CO LTD NO 1558 LONGJIANG BEI RDSep 13, 2018 · CHANGZHOU, China | CHANGZHOU, China | 3 | |
| 2018-03-22 | 483 Zhejiang Huazhou Pharmaceutical Co., Ltd.Mar 22, 2018 · Taizhou, China | Taizhou, China | 8 | |
| 2016-03-11 | 483 Patheon Pharmaceuticals IncMar 11, 2016 · Cincinnati, Ohio | Cincinnati, Ohio | 2 | |
| 2015-09-21 | 483 RXQ Compounding LLCSep 21, 2015 · Athens, Ohio | Athens, Ohio | 10 |
About this profile
What does Christopher T. Middendorf inspect?
Christopher T. Middendorf appears on 8 documents on file covering 7 sites, mostly in China.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.180 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Christopher T. Middendorf is dated Apr 16, 2020.